Intratympanic treatment places medicine through the eardrum into the middle ear, where it can reach the inner ear. It may be discussed for active Meniere disease when vertigo attacks remain disabling despite an appropriate diagnosis and non-invasive management. It is not a first-aid treatment, a guaranteed cure or a standard protocol that is identical for every patient.
Confirm the diagnosis and treatment goal first
Meniere disease is diagnosed from the pattern of spontaneous vertigo attacks, fluctuating ear symptoms and documented sensorineural hearing loss, while considering other causes such as vestibular migraine. Before an injection, the clinician should review the affected ear, current hearing, attack pattern, previous treatment, other medical conditions and what outcome matters most to the patient.
Seek urgent assessment rather than waiting for a routine injection visit if there is sudden new hearing loss, facial weakness, one-sided weakness or numbness, trouble speaking, new double vision, inability to stand or walk, fainting, a sudden severe headache or another new neurological symptom.
Intratympanic steroid
An intratympanic corticosteroid may be offered when active Meniere disease has not responded to non-invasive treatment. Some patients report fewer or less severe vertigo attacks, but the research evidence is limited and does not predict an individual result. Possible harms include temporary pain, dizziness, infection and a persistent eardrum perforation; hearing outcomes and other risks must be discussed for the individual ear.
Intratympanic gentamicin
Gentamicin reduces balance function in the treated ear and may improve vertigo control in selected patients with active disease that has not responded to non-ablative treatment. That same effect can cause or worsen imbalance, and gentamicin can worsen hearing. The decision therefore requires shared discussion of current hearing, balance in the other ear, fall risk, work and driving needs, rehabilitation access and the patient’s priorities.
Why there is no online dose or schedule here
Medicine choice, concentration, number and timing of treatments, stopping rules and follow-up vary by diagnosis, response, hearing and local protocol. They must be prescribed and delivered by an appropriately trained clinician. Do not request a fixed schedule from an online article, reuse a previous plan or place any medicine in the ear yourself.
What to ask before deciding
- How certain is the diagnosis, and is this the ear causing the current attacks?
- Is the goal fewer vertigo attacks, hearing preservation, or both?
- What are the alternatives, including continued non-invasive care?
- What hearing, balance, eardrum and infection risks apply to me?
- How will response and adverse effects be reviewed, and when should I seek urgent help?
- Could I need vestibular rehabilitation or temporary changes to driving and safety-sensitive work?
Aftercare and safety
Follow the treating clinician’s written aftercare instructions. Contact the clinic promptly for severe or worsening pain, discharge, fever, marked new hearing change, persistent severe imbalance or any concern listed in the emergency advice. Do not drive or use machinery while vertigo, imbalance or medicine effects could make control unsafe.
Clinical sources and evidence limits
The AAO-HNS clinical practice guideline for Meniere disease states that clinicians may offer intratympanic steroids to patients with active disease not responsive to non-invasive treatment and should offer intratympanic gentamicin when active disease has not responded to non-ablative treatment. These recommendations do not supply one universal injection protocol.
A randomized comparative trial and a systematic review and network meta-analysis report uncertainty and trade-offs between vertigo control and hearing protection. Study averages are not a personal success rate and should not be presented as a guarantee.
Medical disclaimer: This page provides general education. It does not diagnose Meniere disease, recommend a medicine or protocol, or replace informed consent and individualized care from a qualified clinician.
Read next — from Dr. Porwal's vertigo library